The practical answer
An unchanged product name or magnesium assay does not prove an ingredient is unchanged. Agree which composition, process, site, method and packaging changes require notification, then assess each change against the quality and application evidence used to approve the material.
Define the approved baseline
Retain the signed specification, declared composition, manufacturing and supply-chain identifiers, analytical methods and application-trial references. Include packaging and storage information. Without this baseline, a notification that a material is “equivalent” cannot be assessed consistently by procurement, quality and formulation teams.
Connect the ingredient identifier to the products and batches in which it is used. US dietary-supplement batch records include component identity and quantity information, which helps support this connection. [1] A purchasing nickname alone may not distinguish grades, sites or revised specifications.
Agree notification triggers
Set notification timing and implementation expectations contractually with the supplier. The appropriate notice period depends on your development and inventory needs; this article does not claim that one number is a universal legal requirement. Include a route for urgent deviations and changes discovered after shipment.
| Potential change | Review question |
|---|---|
| Composition or source material | Does the approved identity, label or ingredient definition change? |
| Manufacturing site or process | Could quality attributes or supply qualification be affected? |
| Analytical method or reference | Are new results comparable with the historical specification? |
| Particle characteristics or physical processing | Does the approved formulation or filling behavior still hold? |
| Packaging or storage instructions | Is the existing stability and handling rationale still applicable? |
| Distribution or repacking arrangement | Is traceability preserved through the revised supply chain? |
On smaller screens, scroll the table horizontally.
Assess the change before calling it equivalent
For example, changing an assay method can shift reported results even when the material is unchanged. A method comparison may therefore be more useful than widening a specification to accommodate the new numbers. Conversely, an unchanged elemental assay does not rule out a physical change that affects filling or dispersion.
- Describe exactly what changed, why it changed and which lots are affected.
- Compare the new material with the approved baseline using relevant documents and data.
- Decide whether analytical bridging, application trials, stability work or regulatory review is needed.
- Define the first acceptable lot, transition inventory and any temporary restrictions.
- Record approval, rejection or required additional evidence through the responsible quality process.
Close the loop after implementation
Identify the initial changed lots and review the planned incoming and production evidence. Update controlled specifications, purchasing instructions and relevant technical briefs. Keep superseded documents available for traceability rather than silently overwriting the history.
Laboratory control requirements include criteria for methods and reference materials, reinforcing the need to review changes to how evidence is produced. [2] This workflow is a practical supplier-management framework, not a complete quality agreement or a claim that any particular supplier has accepted these terms. Use it to make the responsibilities and evidence needed for your own products explicit.